Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Acta Haematologica|October 30, 2003
Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's diseaseM Helen Huls, Cliona M Rooney, Helen E HeslopImmunological Reviews|December 17, 2013
A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19Harjeet Singh, Helen Huls, Partow Kebriaei, et al.Current Hematologic Malignancy Reports|February 4, 2014
Driving CAR-based T-cell therapy to successBipulendu Jena, Judy S Moyes, Helen Huls, et al.Cancer Research|November 15, 2011
Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastasesGangxiong Huang, Ling Yu, Laurence Jn Cooper, et al.Plos One|March 8, 2013
Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trialsBipulendu Jena, Sourindra Maiti, Helen Huls, et al.Leukemia & Lymphoma|June 7, 2006
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantationCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapyUluhan Sili, M Helen Huls, Alan R Davis, et al.Transplantation|September 17, 2004
Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytesSamart Pakakasama, Gretchen M Eames, Michael C Morriss, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomasZhensheng Liu, Barbara Savoldo, Helen Huls, et al.Blood|November 2, 2002
Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignanciesStephen Gottschalk, Oliver L Edwards, Uluhan Sili, et al.Pageof 6